Wordt geladen...
Inhibition of XPO1 enhances cell death induced by ABT‐199 in acute myeloid leukaemia via Mcl‐1
The antiapoptotic Bcl‐2 family proteins play critical roles in resistance to chemotherapy in acute myeloid leukaemia (AML). The Bcl‐2‐selective inhibitor ABT‐199 (Venetoclax) shows promising antileukaemic activity against AML, though Mcl‐1 limits its antileukaemic activity. XPO1 is a nuclear exporte...
Bewaard in:
| Gepubliceerd in: | J Cell Mol Med |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237582/ https://ncbi.nlm.nih.gov/pubmed/30596398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13886 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|